Academy Response to COVID-19

Sustainable Development Goals


Since the beginning of the pandemic, the InterAcademy Partnership (IAP) issued three communiqués related to the crisis: the IAP Communiqué on the COVID-19 pandemic, a call for collective action on the global scale to improve and accelerate the use of research and its outputs for the global public good; the IAP Communiqué on Green Recovery, that highlights that fact that only a low-carbon recovery can generate co-benefits for social equity, the environment, and human health; and the IAP Communiqué on the Development and Distribution of Vaccines against COVID-19, whose main messages is that cutting corners in the race for a COVID-19 vaccine, anti-vaxxers, and vaccine nationalism are all a public health threat.

Furthermore, IAP launched the IAP COVID-19 Expert Group, a Group charged with responding to inquiries routed through academies related to the ongoing COVID-19 pandemic across a broad range of health, social, environmental and other direct and indirect consequences (more info on the second tab of this page). 

In 2021 IAP also organized the IAP Global Webinar on Countering Vaccine Hesitancy that took place on Tuesday 23 March  and was designed to help academies prepare for national vaccination efforts (further details on the event, the webinar recording and speakers’ presentations are available at this link).

During 2021 World Immunization Week, IAP released an infographic to shed some light on the different types of COVID-19 vaccines, how they are developed, and how they work, and 5 bite-size videos that present aspects of vaccine science, regulation and the ‘infodemic’ in manageable nuggets of information.

In addition, many IAP member academies around the world are playing their own part in national or regional initiatives – helping to ensure that trustworthy and credible information is reaching as many people as possible, much of it in local languages.

Here we have collated (and will continue to update) information being provided by more than 140 national, regional and global academies and academy networks. For an updated summary of IAP’s COVID-19 related activities, please click here

IAP member academies are responding by: 

  • Providing evidence-based advice to governments at the municipal, national and regional level by participating in governmental task forces and commissions, supporting real-time policy review, synthesizing and distilling the best available scientific evidence, and by issuing statements and recommendations for decision-makers
  • Establishing expert databases for decision-makers with relevant expertise
  • Conducting public outreach to help their communities understand public health guidance, including through translation into local languages and engaging migrant communities
  • Engaging with the media to ensure scientifically accurate information is available to all
  • Sharing data and experiences amongst their members and with other academies in their region and gathering lessons learned
  • Conducting COVID-19 related research and modelling in academies with their own research facilities
  • Providing technical training, for example via online telemedicine courses, diagnostic laboratory techniques
  • Providing fast-track reviews of COVID-19 related-research proposals 

Additional links to other trusted resources are available via this news article: IAP stands side-by-side with science in the fight against coronavirus.

From national academies

From global and regional academies and networks

Trusted sources on vaccines

Other reputable sources on Covid-19





Understanding Long Covid
The science of immunisation
RIA's Vaccine Questions Podcast
The World Post COVID-19
The challenges of COVID-19
IAP Secretariat and COVID-19


Contact Person
Advisory Panel

The IAP COVID-19 Advisory Group brings together a wealth of multi-disciplinary expertise nominated by its member academies. It has been established to respond to inquiries and requests for advice related to the ongoing pandemic. The multi-disciplinary nature of the Group will allow IAP to respond to a broad range of health, social, environmental and other direct and indirect consequences of the pandemic.
Requests for such advice should be submitted by IAP member academies*. Requests from other bona fide organizations are accepted if submitted through an IAP member academy.



Pakistan Academy of Sciences
National Academy of Medicine of Brazil
Cuban Academy of Sciences
Chinese Academy of Sciences
Caribbean Academy of Sciences & IAP Young Physician Leader
Académie Nationale de Médecine, France
National Academy of Medicine, US
Academy of Scientific Research & Technology, Egypt
Global Young Academy
Academy of Science of South Africa (ASSAf)
Academy of Medical Sciences, UK
The Council of Finnish Academies
Indian National Science Academy
National Academy of Sciences, US
Accademia Nazionale dei Lincei, Italy
Nigerian Academy of Science
Nigerian Academy of Science
Ghana Academy of Arts and Sciences
Academy of Science of South Africa (ASSAf)
Chinese Academy of Engineering
Chinese Academy of Engineering
Chilean Academy of Medicine
Expert Group

Suminori Akiba, Science Council of Japan - Epidemiology
Fernando Arenzana-Seisdedos, Chinese Academy of Sciences - Virology, Epidemiology
Yiming Bao, Chinese Academy of Sciences - Virology, Data Analytics, contact tracing networks/mobile software system
Mauricio Barreto, Brazilian Academy of Sciences - Epidemiology, Public health,
Rafael Bello, Cuban Academy of Sciences - Mathematical modelling, Data Analytics 
Yoav Benjamini, Israel Academy of Sciences and Humanities - Data Science
Eyal Benvenisti, Israel Academy of Sciences and Humanities - International law
Patrick Berche, Academie Nationale de Medecine - Infectious diseases, Bacteriology
Michal Biron, Global Young Academy - Social determinants of health, Social sciences, Ethics
Jeanne Brugere-Picoux, Academie Nationale de Medecine (France)Veterinary Medicine
Yves Buisson, Academie Nationale de Medecine (France)Infectious diseases
Stephanie Burton, Academy of Science of South Africa - Ethics, Scientific Literacy, Public Health 
Geoff Chase, Royal Society of New Zealand Te Aparangi - Critical care medicine, Mathematical modelling
Miodrag Čolić, Serbian Academy of Sciences and Arts - Immunology
Philip Dawid, The Royal Society (UK) - Statistics
María Guadalupe Guzmán Tirado, Cuban Academy of Sciences - Virology, Epidemiology
Luis Saturnino Herrera Martinez, Cuban Academy of Sciences - Virology, Epidemiology
Didier Houssin, Academie Nationale de Medecine (France) - Public Health
Abdel Meguid Kassem, Academy of Scientific Research & Technology (Egypt), Public health
Rees Kassen, Global Young Academy - Epidemiology, Science literacy
Lemme Prica Kebaabetswe, Botswana Academy of Science - Virology, microbiology, immunology
Dominique Kerouedan, Academie Nationale de Medecine (France)Social determinants of health, Public health
Junpeng Li, Global Young Academy - Social sciences
Daniel Limonta, Global Young Academy - Virology, Public health, Pandemic research
Gábor B. Makara, Hungarian Academy of Sciences - Ethics, Science literacy, Public health
Alemka Markotić, Croatian Academy of Sciences and Arts - Virology, Infectious diseases, Critical care medicine
Pedro Mas Bermejo, Cuban Academy of Sciences - Virology, Epidemiology, Infectious diseases
Hamid Mobasheri, University of Tehran - Pandemic research, Biophysics, Public health
Jaime Montoya, National Academy of Science and Technology (Philippines) - Infectious diseases, Public health, Ethics
Ali Moosavi-Movahedi, The Academy of Sciences of IR Iran - Biophysical Chemistry
Maria Concetta Morrone, Accademia Nazionale dei Lincei (Italy)  - Physiology - Neurosciences
Sununguko Wata Mpoloka, Botswana Academy of Science - Molecular Biology & Genetics
Jorge Núñez Jover, Cuban Academy of Sciences - Social sciences, Social determinants of health, Ethics
Pamela Pennington Aycinena, Academy of Medical, Physical &Natural Sciences of Guatemala - Public health Microbiology
Wolfgang Preiser, Academy of Science of South Africa  - Virology, Epidemiology, Infectious diseases
Mika Rämet,  Council of Finnish Academies - Critical care medicine
Elisa Reis, Brazilian Academy of Sciences - Social sciences, Ethics
Andrea Rinaldo, Accademia Nazionale dei Lincei (Italy) - Infectious diseases, Pandemic research
Christine Rouzioux, Academie Nationale de Medecine (France)Virology
Birgit Schippers, Royal Irish Academy- Ethics of new technologies, Social Sciences, Human rights
Luis Carlos Silva Atcaguer, Cuban Academy of Sciences - Mathematical modelling, Data Analytics, Public health
Stephen Simpson, Australian Academy of Science - Public health, nutritional sciences, Mathematical modelling
Sameh Hamdy Soror, Academy of Scientific Research & Technology (Egypt) - Science literacy
Amilcar Tanuri, Brazilian Academy of Sciences - Virology, Public health, Infectious diseases, Pandemic research
Gergely Toldi, Global Young Academy & IAP Young Physician Leader - Critical care medicine, Infectious diseases
Raivo Uibo, Estonian Academy of Sciences - Immunology
Olli Vapalahti Vapalahti, Council of Finnish Academies - Virology
Luis Velazquez-Perez, Cuban Academy of Sciences - Epidemiology, Neurology,Neurophysiology
Ludmila Vīksna, Latvian Academy of Sciences - Infectious diseases
Ville Vuorinen, Council of Finnish Academies - Computational physics
Qihui Wang, Chinese Academy of Sciences - Virology, Public health, Infectious diseases
Alan Wilson, Royal Society (UK) - Epidemiology, Mathematical modelling, Social sciences
Wolff Reyes Marcelo J., Academia Chilena de Medicina - Infectious Diseases
Xiaoling Xu, Chinese Academy of Sciences - Critical care medicine, Infectious diseases
Wen Zhou, Chinese Academy of Sciences - Psychology


* IAP member academies have been provided by a link through which queries should be submitted. For further information, please contact


Contact Person


Report Countering COVID-19 Vaccine Hesitancy
Release date:
Other Long-Term Social Impacts of the Covid-19 Pandemic
Policy for Science, Other
Other Crises: economy, society, law, and culture. Towards a less vulnerable humankind
Other S20 statement on Pandemic preparedness and the role of science
Health, Sustainable Development Goals, Other
Communique Strengthening research on COVID-19 during the pandemic
Publication Enhancing COVID-19 Vaccine Acceptance in Canada cover
Release date:
Enhancing COVID-19 Vaccine Acceptance in Canada LEADING AUTHORING INSTITUTION:
Other Les différents types de vaccins COVID-19
Release date:
Les différents types de vaccins COVID-19 LEADING AUTHORING INSTITUTION:
Other types of COVID-19 vaccines infographic
Release date:
The different types of COVID-19 vaccines LEADING AUTHORING INSTITUTION:
Publication Investing in a Better Future: Higher Education and Post-COVID Canada
Health, Policy for Science
Publication Beyond the COVID-19 Crisis: Building on Lost Opportunities in the History of Public Health
Publication he Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era
Publication Achieving the Public Health Potential of COVID-19 Vaccines
Environment & Climate, Health
Communique cover
Publication Cover
Release date:
The SARS-CoV-2 genome: variation, implication and application LEADING AUTHORING INSTITUTION:
Communique cover
Energy, Environment & Climate, Health
Communique cover
Other IANAS statement on COVID-19
Release date:
Communique CovidCover
Release date: